share_log
Benzinga ·  May 7 06:14
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment